Orange, Calif., June 1, 2021 With its current gift, longtime UCI Health benefactor the Chao family has committed $50 million since 1995 to UCI Health toward advancing cancer care in Orange County and beyond. The familys latest gift will name the cancer center at the new UCI Medical Center in Irvine, expanding access to leading-edge cancer treatments and therapies, promising clinical trials, and world-class cancer care driven by the latest in precision medicine.
Few families have been as generous in support of their fellow residents of Orange County as the Chao family, said Chancellor Howard Gillman. This latest extraordinary gift is testament to their belief in the power of academic medicine to lead the fight against cancer and to provide the best and most up-to-date care to cancer patients.
The Chao Family Comprehensive Cancer Center and Ambulatory Care will be one of three medical facilities at the new $1.2 billion medical center adjacent to the UCI campus; the others are a 144-bed acute care hospital with an emergency department and the Center for Advanced Care. The cancer care center is strategically located at the new medical center campus in Irvine to allow patients to receive multidisciplinary care by interprofessional and integrative teams working together to apply the latest innovations from university-backed clinical research.
The Chao familys commitment to UCI and the fight against cancer has brought much-needed hope to patients and their families over the past 25 years, said Steve A.N. Goldstein, M.A., M.D., Ph.D., FAAP, UCI vice chancellor for health affairs. Their most recent gift extends the opportunity for cancer patients to receive lifesaving therapies and empowers the worlds top cancer clinician-scientists to advance cancer treatment through personalized healthcare. This is only possible at an academic health center committed to developing and applying advanced AI, machine-learning, genomics and therapeutics to clinical practice.
More than anyone else, the Chao familys generosity and dedication has changed the face of cancer care and research in Orange County, said Richard Van Etten, M.D., Ph.D., director of UCIs Chao Family Comprehensive Cancer Center in Orange, the only National Cancer Institute-designated comprehensive cancer center based in Orange County. The Chao familys investment allows UCI Health to treat the most complex cancers, and patients benefit from the power of the University of California Cancer Consortium.
Since their first gift to the university in 1995, three generations of Chaos have supported the growth of UCIs cancer program, including expanded clinical care and advanced research facilities and the creation last year of Orange Countys only adult hematopoietic stem cell/bone marrow transplant program. Today, UCIs Chao Family Comprehensive Cancer Center in Orange is one of only 51 NCI-designated centers across the U.S. those that meet the highest standards for an institutions commitment to and excellence in cancer research and clinical care.
Doing good in our community has always been very important to our family, said Allen Chao. We are proud to continue our partnership with UCI and to know that community members from all walks of life benefit from the lifesaving treatments offered here.
Its a value passed down to us from our matriarch and patriarch, Hsu Hwa Chao and Hsi Hsiung Chao, he said.
In 1999, Allen Chao developed stomach cancer. He sought the care of UCI Health gastroenterologistDr. Kenneth Chang, who helped to remove all signs of the disease. Chang, head of gastrointestinal oncology, also directs UCIs Chao Family Comprehensive Digestive Disease Center (CDDC), supported by the Chao family as part of its vision to expand access to cancer care.
The CDDC is a multidisciplinary center where gastroenterologists, hepatologists, oncologists, surgeons and other specialists work in concert to provide the best care for the most complex digestive diseases, including cancer of the colon, liver, stomach, esophagus and pancreas. Under Changs leadership and with the support of the Chao family, the CDDC has become a leader in innovation and clinical care, advancing research and clinical trials on the development of treatments for digestive cancers. Chang has pioneered the development of endoscopic ultrasound guided fine-needle aspiration and injection, techniques that have revolutionized the intervention and treatment of many gastrointestinal diseases and cancers.
The Chao family has expanded access to the most innovative treatments for those with cancer and those with gastrointestinal diseases, which are also highly prevalent among the Asian population, Chang said.
The Chao familys commitment is a key to extending access to UCI Health cancer care and clinical trials to residents across the region. The new cancer center and hospital are slated to begin construction later this year and open in late 2023 and 2025, respectively, according to UCI Health CEO Chad Lefteris.
We encourage others to do good in their community in whatever way they can, Chao said. Philanthropy can take many forms and is not limited to financial support.
I commend the Chao family for their naming gift to the Comprehensive Cancer Center and Ambulatory Care facility at the UCI Medical Center in Irvine, and we are grateful for UCIs continued partnership and contributions to maintaining the wellbeing of Irvine, said Irvine Mayor Farrah Khan. This new facility will provide the world-class cancer research and care that befits the unsurpassed quality of life for Irvine residents by providing additional healthcare options and new jobs for the community.
Orange Countys landmark cancer center
Established in 1989 as Orange Countys first cancer center, the UCI facility in Orange achieved its initial National Cancer Institute cancer center designation in 1994 and comprehensive designation in 1997. The familys landmark 1995 gift catalyzed the universitys efforts to earn this status.
The significance for Orange County was profound. A region with a population greater than that of 20 states now had an institution where people with advanced-stage or treatment-resistant diseases could receive world-class cancer care advanced by basic and translational research, including access to early-phase clinical trials involving the very latest therapies.
A strong research base, in particular, helps drive progress, Van Etten said. It is our mission to translate the findings of basic research into treatments that can benefit patients. Institutions lacking their own research base can follow and adopt advances developed elsewhere, but they cannot lead in the same way comprehensive cancer centers that integrate research with clinical care can.
The current gift furthers UCI efforts to expand cancer prevention and screening, address disparities and provide equitable access to specialty cancer care. For example, enrollment in potentially lifesaving clinical trials increased by more than 260 percent between 2015 and 2020.
UCIs advancements in cancer care are made possible thanks to the Chao familys friendship and support, and we are excited to be able to offer this level of care across Orange County, Lefteris said. In just the last five years, the UCI Chao Family Comprehensive Cancer Center in Orange and our community locations across Orange County have seen more than 400,000 patient visits.
David Liu is one of the people whose lives were saved by UCI Health cancer specialists supported by the Chao family. Diagnosed with stage 3 colon cancer a decade ago at a community hospital, the Orange County resident turned to the regions only academic health system for treatment.
This is a wonderful organization, and I was treated by many excellent doctors, nurses and other staff, said Liu, an engineer and part-time musician whose band supports fundraisers for several community groups. It really touches me that the Chao family has committed to a vision of a cancer center available for everybody.
About the UCI Health: UCI Healthis the clinical enterprise of the University of California, Irvine. Patients can access UCI Health at primary and specialty care offices across Orange County and at its main campus,UCI Medical Center in Orange, Calif. The 418-bed acute-care hospital, listed among Americas Best Hospitals byU.S. News & World Reportfor 20 consecutive years, provides tertiary and quaternary care, ambulatory and specialty medical clinics, as well as behavioral health and rehabilitation services. UCI Medical Center is home to Orange Countys onlyNational Cancer Institute-designated comprehensive cancer center,high-risk perinatal/neonatal programandAmerican College of Surgeons-verified Level I adult and Level II pediatric trauma centerandregional burn center. It is the primary teaching hospital for theUCI School of Medicine. UCI Health serves a region of nearly 4 million people in Orange County, western Riverside County and southeast Los Angeles County. Follow us onFacebookandTwitter.
About the University of California, Irvine: Founded in 1965, UCI is the youngest member of the prestigious Association of American Universities and is ranked among the nations top 10 public universities by U.S. News & World Report. The campus has produced three Nobel laureates and is known for its academic achievement, premier research, innovation and anteater mascot. Led by Chancellor Howard Gillman, UCI has more than 36,000 students and offers 224 degree programs. Its located in one of the worlds safest and most economically vibrant communities and is Orange Countys second-largest employer, contributing $7 billion annually to the local economy and $8 billion statewide. For more on UCI, visit http://www.uci.edu.
About UCIs Brilliant Future campaign:Publicly launched on Oct. 4, 2019, the Brilliant Future campaign aims to raise awareness and support for UCI. By engaging 75,000 alumni and garnering $2 billion in philanthropic investment, UCI seeks to reach new heights of excellence instudent success, health and wellness, research and more. Learn more by visitingbrilliantfuture.uci.edu.
Media access: Radio programs/stations may, for a fee, use an on-campus ISDN line to interview UCI faculty and experts, subject to availability and university approval. For more UCI news, visit news.uci.edu. Additional resources for journalists may be found at communications.uci.edu/for-journalists.
Read the original here:
Chao family gifts to UCI Health for cancer care top $50 million - UCI News
- Quizartinib Added to Chemotherapy Demonstrates Superior Overall Survival Compared to Chemotherapy Alone in Adult Patients with Newly Diagnosed... - November 22nd, 2021
- Researcher awarded $12 million for a stem cell trial to improve outcomes of young blood cancer patients - Stanford Medical Center Report - November 8th, 2021
- Heart Tissue in a Dish Reveals New Links Between Neurodegeneration and Heart Disease - PRNewswire - November 8th, 2021
- Vaccines less effective at protecting against severe COVID-19 in immunocompromised adults - EurekAlert - November 8th, 2021
- Coherus BioSciences Announces CMS Has Extended Enhanced Medicare Reimbursement for UDENYCA in the 340B Hospital Setting Through Year-End 2022 -... - November 8th, 2021
- Precision BioSciences Announces Two Oral Presentations Highlighting Updated Interim Data from Lead PBCAR0191 CAR T Immunotherapy for Relapsed and... - November 8th, 2021
- All you need to know about the COVID boosters available in Somerset County - Daily American Online - November 8th, 2021
- Asia-Pacific Cell Therapy Market 2021-2028 - Opportunities in the Approval of Kymriah and Yescarta - PRNewswire - August 5th, 2021
- Fate Therapeutics Announces Treatment of First Patient in Landmark Phase 1 Clinical Trial of ... - The Bakersfield Californian - August 5th, 2021
- IDH1 Inhibitors, CAR T-Cell Therapy, and Third-Generation TKIs Refresh Relapsed/Refractory Leukemia Landscape - OncLive - August 5th, 2021
- Lenzilumab Treatment May Provide Enhanced Likelihood of Survival Without Ventilation in Hospitalized Black and African-American COVID-19 Patients -... - August 5th, 2021
- Is This Small-Cap Biotech a Buy After Its Second Approved Gene Therapy? - Motley Fool - August 5th, 2021
- Defining Cell Culture Lines and Media - The Scientist - August 5th, 2021
- Preimplantation Genetic Testing Demand to Grow by 9% CAGR Annually, through 2031 - BioSpace - August 5th, 2021
- Cell Therapy Global Market Report 2021: COVID-19 Growth and Change to 2030 - ResearchAndMarkets.com - Business Wire - July 7th, 2021
- A New Era For FDA Regulation Of Cell And Tissue Products - Law360 - July 7th, 2021
- UM School Of Medicine Researchers Receive NIH Avant Garde Award For Out-Of-Box, Innovative Concept To Cure HIV And Treat Co-Existing Addiction -... - July 7th, 2021
- Antengene Announces Acceptance of IND Application in China for the Phase II Clinical Trial of Single-Agent Selinexor for the Treatment of... - July 7th, 2021
- The Top Doctors in the Twin Cities, 2021 - Mpls.St.Paul Magazine - July 7th, 2021
- The stem cell market was valued at USD 14.7 billion in 2020, and it is expected - GlobeNewswire - June 8th, 2021
- Innovative Regenerative Medicine Therapies Safety Comes First - FDA.gov - June 8th, 2021
- Early Promise of AntiCLL-1 CAR T-Cell Therapy Reported in Pediatric AML - Cancer Network - June 8th, 2021
- Part 3: Moving Forward and Keeping Stem Cell Treatments Safe - MedShadow - June 8th, 2021
- In Some Heavily Pretreated Patients with R/R MM Ide-Cel Continues to Show Deep and Durable Responses - Targeted Oncology - June 8th, 2021
- Innovative research refines the treatment of patients with advanced cancers and the use of immunotherapy - Network News, Press Releases - Hackensack... - June 8th, 2021
- Mustang Bio to Host Key Opinion Leader Webinar on MB-106 CD20-Targeted CAR T for the Treatment of High-Risk B-Cell Non-Hodgkin Lymphomas and Chronic... - June 8th, 2021
- Karen Hasty Named Among 2021 Super Women In Business by Memphis Business Journal - UTHSC News - June 8th, 2021
- High Overall Response Rates Achieved With Cirmtuzumab/Ibrutinib in MCL and CLL - Targeted Oncology - June 8th, 2021
- New Data on KEYTRUDA (pembrolizumab) Plus LENVIMA (lenvatinib) Versus Sunitinib in First-Line Treatment for Patients With Advanced Renal Cell... - June 8th, 2021
- Sorrento and Researchers at Karolinska Institutet Have Signed a Research Collaboration Agreement on iPSC-Derived Dimeric - GlobeNewswire - June 8th, 2021
- Responses to Tafasitamab/Lenalidomide in DLBCL Sustained at Three Years - Cancer Network - June 8th, 2021
- The regenerative medicine market size to grow at a CAGR of around 30% during the period - GlobeNewswire - June 8th, 2021
- 'Natural Killer Cells' and Other Promising Cancer Treatments - Barron's - April 18th, 2021
- Capturing the Pandemic Experience in Haiku Poetry - Duke Today - April 18th, 2021
- Chemotherapy for Prostate Cancer: When It's Used and What to Expect - Healthline - April 18th, 2021
- Signs that Chemo Is Working: How Effectiveness Is Measured and Defined - Healthline - April 18th, 2021
- Some experts fear next-generation Covid vaccines may be worse - STAT - April 18th, 2021
- How Long is Chemotherapy? What to Expect - Healthline - April 18th, 2021
- Regenerative Medicine - Stem Cell Therapy Little Rock - March 8th, 2021
- Center for Stem Cell Biology & Regenerative Medicine ... - March 8th, 2021
- Dynamic Stem Cell Therapy Offers Regenerative Medicine - Las Vegas Review-Journal - March 8th, 2021
- Anti-EGFR VHH-armed death receptor ligandengineered allogeneic stem cells have therapeutic efficacy in diverse brain metastatic breast cancers -... - March 8th, 2021
- Research Antibodies Market Size to Reach USD 5325.8 Million by 2027 | Increasing R&D Activities in the Fields of Oncology, Neurobiology, and Stem... - March 8th, 2021
- Microwave Processing Isolates Red Ginseng Compounds That Suppress Lung Cancer Metastasis - Genetic Engineering & Biotechnology News - March 8th, 2021
- Longeveron Expands Enrollment Criteria for its Phase 1 RECOVER Trial Evaluating Lomecel-B Infusion to Treat Acute Respiratory Distress Syndrome due to... - March 8th, 2021
- Be The Match BioTherapies Announces Expansion of Multi-Year Strategic Alliance with Orchard Therapeutics to Support European Commercial Launch of... - March 8th, 2021
- Autologous Stem Cell and Non-Stem Cell Based Therapies Market 2021: Focuses at the key worldwide companies to Define, Describe and Analyses the sales... - March 8th, 2021
- Editing Reproduction: CRISPR and preventing heritable diseases, With Dr. Dietrich Egli and Dr. Sam Sternberg - Columbia University Irving Medical... - March 8th, 2021
- U. Cancer Center pilot projects: investigating cancer connections - The Brown Daily Herald - March 8th, 2021
- COVID-19 can kill heart muscle cells, interfere with contraction Washington University School of Medicine in St. Louis - Washington University School... - March 8th, 2021
- Vaccinating by age groups is unfair, particularly to minorities, advisory panel tells CDC - USA TODAY - March 8th, 2021
- Winter Weather Impacting Blood and Platelet Donations - Milwaukee Community Journal - February 17th, 2021
- Joshua Shirk continues to fight the odds; mom says God placed people where they needed to be to help him - Keyser Mineral Daily News Tribune - February 17th, 2021
- Evotec and Medical Center Hamburg-Eppendorf Enter Partnership to Develop iPSC-Based Tissue Therapy for Heart Failure - GuruFocus.com - February 7th, 2021
- ProgenCell - Stem Cell Therapies offers an updated Stem Cell Therapy for Anti Aging Protocol - PR Web - January 30th, 2021
- Doctors urge immunocompromised to get COVID vaccine when it becomes available - KMTV - 3 News Now - January 30th, 2021
- Autologous Stem Cell and Non Stem Based therapies Market Share, Size 2021 Global Industry Future Trends, Growth, Strategies,, Segmentation, In-depth... - January 30th, 2021
- Studies Indicating T-Cells May Be Needed For Long-Term Protection From The SARS-Cov-2 Virus - PRNewswire - January 30th, 2021
- Researchers use patients' cells to test gene therapy for rare eye disease - National Institutes of Health - January 30th, 2021
- Two Gene Therapies Fix Fault in Sickle Cell Disease and -thalassemia - MD Magazine - January 30th, 2021
- If I Have Cancer, Dementia or MS, Should I Get the Covid Vaccine? - Kaiser Health News - January 30th, 2021
- L-MIND Trial Results Show CD19 Antibody Is Reasonable in R/R DLBCL - Targeted Oncology - January 30th, 2021
- Profile of T Cells, Broadly Neutralizing Antibodies, Anti-Viral Targets: COVID-19 Updates - Bio-IT World - January 30th, 2021
- HealthLynked's The Future of Healthcare Summit Brings Healthcare Experts and Technology Innovators from Around the World to Naples, Florida - WFMZ... - January 30th, 2021
- Tevogen Bio Secures Funding from Team of Doctors to Support Clinical Trials of Its Investigational Curative T Cell Therapy for COVID-19 - PRNewswire - January 25th, 2021
- Novel Treatment Leads to Dog's Recovery - The Bark - January 25th, 2021
- Identification and Targeting of ThomsenFriedenreich and IL1RAP | OTT - Dove Medical Press - January 25th, 2021
- Regenerative Medicine Market Size Worth $74831.35 Million With CAGR of 22.27% By 2024 | Segmented by Product Type, Top Manufacturers, By End-User... - January 25th, 2021
- Immunotherapy Inches Forward in Development of Myeloid Malignancies - OncLive - January 14th, 2021
- Cytovia Therapeutics Partners with National Cancer Institute to Develop Novel Gene-Edited, iPSC-Derived GPC3 CAR NK Cells for the Treatment of Solid... - January 14th, 2021
- Kaleido Biosciences Announces Positive Interim Results of Controlled Study of KB109 in Patients with Mild-to-Moderate COVID-19 - BioSpace - January 14th, 2021
- Doctors Make Medical Breakthrough In Treating Severe Cases Of COVID - CBS San Francisco - January 9th, 2021
- Mana joins the hectic fight against solid tumors with an 'off-the-shelf' candidate angling for an IND this year - Endpoints News - January 9th, 2021
- Versiti Blood Centers and Noodles & Company Serve Up Thanks to Blood Donors - PRNewswire - December 31st, 2020
- Global CAR-T Pipeline Insight Report 2020: Overview, Landscape, Therapeutic Assessment, Current Treatment Scenario and Emerging Therapies -... - December 31st, 2020
- 2020 health care year in review - Crain's Cleveland Business - December 31st, 2020
- The Top 10 FDA Oncology Drug Approvals of 2020 - Curetoday.com - December 31st, 2020
- Gut microbiota: How does it interact with the brain? - Medical News Today - December 31st, 2020
- Numerous Indian American STEM Researchers Named Fellows of American Association for the Advancement of Sciences - India West - December 31st, 2020
- Four years after devastating spinal injury, former St. Paul's football player reunites with caregivers - NOLA.com - December 24th, 2020